Uveal melanoma: A study on incidence of additional cancers in the Swedish population

Investigative Ophthalmology and Visual Science

Volumn 47, Issue 1, 2006, Pages 72-77

  Bergman, Louise ^a   Nilsson, Bo ^b   Ragnarsson Olding, Boel ^b   Seregard, Stefan ^a  

^a ST ERIK S EYE HOSPITAL   (Sweden)

^b KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

Author keywords

[No Author keywords available]

Indexed keywords

ARTICLE; CANCER REGISTRY; CANCER RISK; CASE CONTROL STUDY; CONTROLLED STUDY; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; MELANOMA; MORBIDITY; POPULATION RESEARCH; PRIORITY JOURNAL; RISK ASSESSMENT; SWEDEN; UVEA MELANOMA; ADULT; AGED; COMORBIDITY; INCIDENCE; MIDDLE AGED; REGISTER; RISK; RISK FACTOR; SECOND CANCER; UVEA TUMOR;

ADULT; AGED; AGED, 80 AND OVER; CASE-CONTROL STUDIES; COMORBIDITY; FEMALE; HUMANS; INCIDENCE; MALE; MELANOMA; MIDDLE AGED; NEOPLASMS, SECOND PRIMARY; ODDS RATIO; REGISTRIES; RISK FACTORS; SWEDEN; UVEAL NEOPLASMS;

EID: 33644844985     PISSN: 01460404     EISSN: None     Source Type: Journal    
DOI: 10.1167/iovs.05-0884     Document Type: Article

References (54)

1. Mooy CM, Van der Helm MJ, Van der Kwast TH, De Jong PT, Ruiter DJ, Zwarthoff EC. No N-ras mutations in human uveal melanoma: the role of ultraviolet light revisited. Br J Cancer. 1991;64:411-413.
2. Dolin PJ, Johnson GJ. Solar ultraviolet radiation and ocular disease: a review of the epidemiological and experimental evidence. Ophthalmic Epidemiol. 1994;1:155-164.
3. English DR, Armstrong BK, Kricker A, Fleming C. Sunlight and cancer. Cancer Causes Control. 1997;8:271-283.
4. Scotto J, Fraumeni JF Jr, Lee JA. Melanomas of the eye and other noncutaneous sites: epidemiologic aspects. J Natl Cancer Inst. 1976;56:489-491.
5. Seddon JM, Gragoudas ES, Glynn RJ, Egan KM, Albert DM, Blitzer PH. Host factors, UV radiation, and risk of uveal melanoma: a case-control study. Arch Ophthalmol. 1990;108:1274-1280.
6. Vajdic CM, Kricker A, Giblin M, et al. Sun exposure predicts risk of ocular melanoma in Australia. Int J Cancer. 2002;101:175-182.
7. Tucker MA, Shields JA, Hartge P, Augsburger J, Hoover RN, Fraumeni JF Jr. Sunlight exposure as risk factor for intraocular malignant melanoma. N Engl J Med. 1985;313:789-792.
8. Li W, Judge H, Gragoudas ES, Seddon JM, Egan KM. Patterns of tumor initiation in choroidal melanoma. Cancer Res. 2000;60: 3757-3760.
9. Holly EA, Aston DA, Char DH, Kristiansen JJ, Ahn DK. Uveal melanoma in relation to ultraviolet light exposure and host factors. Cancer Res. 1990;50:5773-5777.
10. Singh AD, Rennie IG, Seregard S, Giblin M, McKenzie J. Sunlight exposure and pathogenesis of uveal melanoma. Surv Ophthalmol. 2004;49:419-428.
11. Chang AE, Karnell LH, Menck HR. The National Cancer Data Base report on cutaneous and noncutaneous melanoma: a summary of 84,836 cases from the past decade. The American College of Surgeons Commission on Cancer and the American Cancer Society. Cancer. 1998;83:1664-1678.
12. Mansson-Brahme E, Johansson H, Larsson O, Rutqvist LE, Ringborg U. Trends in incidence of cutaneous malignant melanoma in a Swedish population 1976-1994. Acta Oncol. 2002;41:138-146.
13. Thorn M, Bergstrom R, Adami HO, Ringborg U. Trends in the incidence of malignant melanoma in Sweden, by anatomic site, 1960-1984. Am J Epidemiol. 1990;132:1066-1077.
14. Bergman L, Seregard S, Nilsson B, Ringborg U, Lundell G, Ragnarsson-Olding B. Incidence of uveal melanoma in Sweden from 1960 to 1998. Invest Ophthalmol Vis Sci. 2002;43:2579-2583.
15. Singh AD, Topham A. Incidence of uveal melanoma in the United States: 1973-1997. Ophthalmology. 2003;110:956-961.
16. Vajdic CM, Kricker A, Giblin M, et al. Incidence of ocular melanoma in Australia from 1990 to 1998. Int J Cancer. 2003;105:117-122.
17. Fearon ER. Human cancer syndromes: clues to the origin and nature of cancer. Science. 1997;278:1043-1050.
18. Goldgar DE, Easton DF, Cannon-Albright LA, Skolnick MH. Systematic population-based assessment of cancer risk in first-degree relatives of cancer probands. J Natl Cancer Inst. 1994;86:1600-1608.
19. Hemminki K, Vaittinen P. Familial cancers in a nationwide family cancer database: age distribution and prevalence. Eur J Cancer. 1999;35:1109-1117.
20. Houlston RS, Damato BE. Genetic predisposition to ocular melanoma. Eye. 1999;13:43-46.
21. Mattsson B, Wallgren A. Completeness of the Swedish Cancer Register: non-notified cancer cases recorded on death certificates in 1978. Acta Radiol Oncol. 1984;23:305-313.
22. The Swedish Cancer Registry. In: The National Board of Health and Welfare/The Centre for Epidemiologist/The Swedish Cancer Registry. Available at http://www.sos.se/epc/english/cancereng. htm. Accessed on September 30, 2002.
23. Official Statistics of Sweden. Stockholm: The National Swedish Central Bureau of Statistics Annual Publications; 1960-1998.
24. Coleman M, Douglas A, Hermon C, Peto J. Cohort study analysis with a FORTRAN computer program. Int J Epidemiol. 1986;15: 134-137.
25. Boice JD Jr, Curtis RE, Kleinerman RA, Flannery JT, Fraumeni JF Jr. Multiple primary cancers in Connecticut, 1935-82. Yale J Biol Med. 1986;59:533-545.
26. Tucker MA, Boice JD Jr, Hoffman DA. Second cancer following cutaneous melanoma and cancers of the brain, thyroid, connective tissue, bone, and eye in Connecticut, 1935-82. Natl Cancer Inst Monogr. 1985;68:161-189.
27. Teppo L, Pukkala E, Saxen E. Multiple cancer: an epidemiologic exercise in Finland. J Natl Cancer Inst. 1985;75:207-217.
28. Swerdlow AJ, Storm HH, Sasieni PD. Risks of second primary malignancy in patients with cutaneous and ocular melanoma in Denmark, 1943-1989. Int J Cancer. 1995;773-779.
29. Turner BJ, Siatkowski RM, Augsburger JJ, Shields JA, Lustbader E, Mastrangelo MJ. Other cancers in patients with uveal melanoma and their families. Am J Ophthalmol. 1989;107:601-608.
30. Lischko AM, Seddon JM, Gragoudas ES, Egan KM, Glynn RJ. Evaluation of prior primary malignancy as a determinant of uveal melanoma: a case-control study. Ophthalmology. 1989;96:1716-1721.
31. Holly EA, Aston DA, Ahn DK, Kristiansen JJ, Char DH. No excess prior cancer in patients with uveal melanoma. Ophthalmology. 1991;98:608-611.
32. Kindy-Degnan N, Char D, Kroll S. Coincident systemic malignant disease in patients with uveal melanoma. Can J Ophthalmol. 1989;24:204-206.
33. Collaborative Ocular Melanoma Study Group. Second primary cancers after enrollment in the COMS trials for treatment of choroidal melanoma: COMS Report No. 25. Arch Ophthalmol. 2005;123:601-604.
34. Easton DF, Steele L, Fields P, et al. Cancer risks in two large breast cancer families linked to BRCA2 on chromosome 13q12-13. Am J Hum Genet. 1997;61:120-128.
35. Sinilnikova OM, Egan KM, Quinn JL, et al. Germline brca2 sequence variants in patients with ocular melanoma. Int J Cancer. 1999;82:325-328.
36. Hearle N, Damato BE, Humphreys J, et al. Contribution of germline mutations in BRCA2, P16(INK4A), P14(ARF) and P15 to uveal melanoma. Invest Ophthalmol Vis Sci. 2003;44:458-462.
37. Scott RJ, Vajdic CM, Armstrong BK, et al. BRCA2 mutations in a population-based series of patients with ocular melanoma. Int J Cancer. 2002;102:188-191.
38. Iwamoto S, Burrows RC, Kalina RE, et al. Immunophenotypic differences between uveal and cutaneous melanomas. Arch Ophthalmol. 2002;120:466-470.
39. Singh AD, Wang MX, Donoso LA, Shields CL, De Potter P, Shields JA. Genetic aspects of uveal melanoma: a brief review. Semin Oncol. 1996;23:768-772.
40. Soufir N, Bressac-de Paillerets B, Desjardins L, et al. Individuals with presumably hereditary uveal melanoma do not harbour germline mutations in the coding regions of either the P16INK4A, P14ARF or cdk4 genes. Br J Cancer. 2000;82:818-822.
41. Wang X, Egan KM, Gragoudas ES, Kelsey KT. Constitutional alterations in p16 in patients with uveal melanoma. Melanoma Res. 1996;6:405-410.
42. Edmunds SC, Kelsell DP, Hungerford JL, Cree IA. Mutational analysis of selected genes in the TGFbeta, Wnt, pRb, and p53 pathways in primary uveal melanoma. Invest Ophthalmol Vis Sci. 2002;43: 2845-2851.
43. Cree IA. Cell cycle and melanoma: two different tumours from the same cell type. J Pathol. 2000;191:112-114.
44. Elwood JM, Jopson J. Melanoma and sun exposure: an overview of published studies. Int J Cancer. 1997;73:198-203.
45. Singh AD, Shields CL, Shields JA, Eagle RC, De Potter P. Uveal melanoma and familial atypical mole and melanoma (FAM-M) syndrome. Ophthalmic Genet. 1995;16:53-61.
46. van Hees CL, Jager MJ, Bleeker JC, Kemme H, Bergman W. Occurrence of cutaneous and uveal melanoma in patients with uveal melanoma and their first degree relatives. Melanoma Res. 1998;8:175-180.
47. Hammer H, Toth-Molnar E, Olah J, Dobozy A. Cutaneous dysplastic naevi: risk factor for uveal melanoma. Lancet. 1995;346:255-256.
48. Bataille V, Pinney E, Hungerford JL, Cuzick J, Bishop DT, Newton JA. Five cases of coexistent primary ocular and cutaneous melanoma. Arch Dermatol. 1993;129:198-201.
49. Hurst EA, Harbour JW, Cornelius LA. Ocular melanoma: a review and the relationship to cutaneous melanoma. Arch Dermatol. 2003;139:1067-1073.
50. Seregard S, af Trampe E, Mansson-Brahme E, Kock E, Bergenmar M, Ringborg U. Prevalence of primary acquired melanosis and nevi of the conjunctiva and uvea in the dysplastic nevus syndrome: a case-control study. Ophthalmology. 1995;102:1524-1529.
51. Scull JJ, Alcocer CE, Deschenes J, Burnier MN Jr. Primary choroidal melanoma in a patient with previous cutaneous melanoma. Arch Ophthalmol. 1997;115:796-798.
52. Gilbert CM, el Baba F, Schachat AP, Grossniklaus H, Green WR. Nonsimultaneous primary choroidal and cutaneous melanomas: report of a case. Ophthalmology. 1987;94:1169-1172.
53. Shors AR, Iwamoto S, Doody DR, Weiss NS. Relationship of uveal and cutaneous malignant melanoma in persons with multiple primary tumors. Int J Cancer. 2002;102:266-268.
54. Hemminki K, Zhang H, Czene K. Association of first ocular melanoma with subsequent cutaneous melanoma: results from the Swedish Family-Cancer Database. Int J Cancer. 2003;104:257-258.